首页> 外文期刊>Toxicology: An International Journal Concerned with the Effects of Chemicals on Living Systems >Mechanism underlying hypokalemia induced by trimethyltin chloride: Inhibition of H+/K+-ATPase in renal intercalated cells.
【24h】

Mechanism underlying hypokalemia induced by trimethyltin chloride: Inhibition of H+/K+-ATPase in renal intercalated cells.

机译:三甲基氯化锡诱导的低钾血症的潜在机制:肾插层细胞中H + / K + -ATPase的抑制。

获取原文
获取原文并翻译 | 示例
       

摘要

Trimethyltin chloride (TMT), a byproduct of plastic stabilizers, has caused 67 poisoning accidents in the world; more than 98% (1814/1849) of the affected patients since 1998 have been in China. As a long-established toxic chemical, TMT severely affects the limbic system and the cerebellum; however, its relationship with hypokalemia, a condition observed in the majority of the cases in the last decade, remains elusive. To understand the mechanism underlying hypokalemia induced by TMT, Sprague-Dawley (SD) rats were administered TMT to determine the relationship between H(+)/K(+)-ATPase activity and the blood and urine K(+) concentration and pH, respectively. H(+)/K(+)-ATPase protein and mRNA were observed too. In vitro changes to intracellular pH, K(+) channels in renal cells were measured. The results showed that TMT increased potassium leakage from the kidney, raised urine pH, and inhibited H(+)/K(+)-ATPase activity both in vitro and in vivo. In the tested animals, H(+)/K(+)-ATPase activity was positively correlated with the decrease of plasma K(+) and blood pH but was negatively correlated with the increase of urine K(+) and urine pH (P<0.01), while TMT did not change the expression of H(+)/K(+)-ATPase protein and mRNA. TMT decreased intracellular pH and opened K(+) channels in renal intercalated cells. Our findings suggest TMT can directly inhibit the activity of H(+)/K(+)-ATPases in renal intercalated cells, reducing urine K(+) reabsorption and inducing hypokalemia.
机译:塑料稳定剂的副产品三甲基氯化锡(TMT)在世界范围内已造成67起中毒事故;自1998年以来,超过98%(1814/1849)受影响的患者在中国。作为一种长期存在的有毒化学物质,TMT严重影响边缘系统和小脑。然而,它与低血钾的关系(在过去十年中大多数病例中都观察到)仍然难以捉摸。为了了解TMT诱导的低钾血症的潜在机制,对Sprague-Dawley(SD)大鼠进行了TMT给药,以确定H(+)/ K(+)-ATPase活性与血液和尿液K(+)浓度和pH之间的关系,分别。 H(+)/ K(+)-ATPase蛋白和mRNA也被观察到。体外对肾细胞中细胞内pH,K(+)通道的变化进行了测量。结果表明,无论在体内还是体外,TMT均可增加钾从肾脏的漏出,提高尿液的pH值并抑制H(+)/ K(+)-ATPase活性。在测试的动物中,H(+)/ K(+)-ATPase活性与血浆K(+)和血液pH的降低呈正相关,但与尿K(+)和尿pH的升高呈负相关(P <0.01),而TMT不会改变H(+)/ K(+)-ATPase蛋白和mRNA的表达。 TMT降低了细胞内pH值,并在肾插层细胞中打开了K(+)通道。我们的发现表明TMT可以直接抑制肾插层细胞中H(+)/ K(+)-ATPase的活性,减少尿K(+)的重吸收并诱导低钾血症。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号